Effect of Sarcopenia on Cardiovascular Disease Risk Factors in Obese Postmenopausal Women

• DOI: 10.1038/oby.2006.267
• Publication Date: 2008-04-23T15:23:07Z
• Authors: Mylène Aubertin‐L...; Christine Lord; Éric D.B. Goulet; Abdelouahed Khalil; Isabelle J. Dionne
• Keywords: Sarcopenic obesity; Lipid Profile

To compare sarcopenic-obese and obese postmenopausal women for risk factors predisposing to cardiovascular disease (CVD) determine whether there may be a relationship between muscle mass metabolic in women.In this cross-sectional study, 22 healthy (mean age, 66 +/- 5 years; mean BMI, 27 3 kg/m(2)) were divided into two groups matched age (+/-2 years) fat (FM) (+/-2%). Sarcopenia was defined as index of <14.30 kg fat-free (FFM)/m(2) (which corresponds 1 standard deviation below the values young reference population), obesity an FM >35% World Health Organization guidelines). FM, FFM (measured by DXA), daily energy expenditure (accelerometry), dietary intake (3-day record), blood biochemical analyses (lipid profile, insulin, glucose, C-reactive protein) obtained. Visceral (VFM) calculated equation Bertin, which estimates VFM from DXA measurements.Obese had more (p = 0.006), abdominal 0.047), 0.041) worse lipid profile [p 0.040 triglycerides; p 0.004 high-density lipoprotein (HDL); 0.026 total cholesterol/HDL] than women. Obese also ingested significantly animal 0.001) less vegetal proteins 0.013), although both similar protein 0.967).Sarcopenia seems associated with lower CVD With increase number aging people, health implications being merit attention.